RSV
Vaccination in a post-pandemic world
Covid-19 and RSV vaccination services have transitioned in the years since the pandemic. We speak with two leading community pharmacists about how they now provide these services. KEY POINTS: Covid-19 …
RSV vaccine added to NIP for over 75s
Government moves to eliminate cost barrier to accessing the RSV vaccine for older Australians The federal government is investing $445.3 million to deliver free respiratory syncytial virus (RSV) vaccines to eligible patients from …
RSV vax decision deferred
NIP listing proposal for immunising infants and young children temporarily knocked back for legislative reasons A decision on the proposed NIP listing of respiratory syncytial virus (RSV) vaccine nirsevimab (Beyfortus) …
Administration errors reported with RSV prevention products
Regulator warns of “product administration errors” in the provision of respiratory syncytial virus (RSV) vaccines and monoclonal antibody medications Pharmacists urged to plan carefully to prevent dispensing and administration errors related …
TGA issues updated warnings for RSV vaccines
Safety information for two RSV vaccines is being updated to “reflect the low risk of people contracting Guillain-Barre syndrome following vaccination Immunisers are being advised to be aware of the …
RSV protection under NIP
With the new RSV vaccine for pregnant women about to become available, PDL has some advice for pharmacists providing vaccination services From 3 February 2025, the respiratory syncytial virus (RSV) …
RSV: a pharmacist’s role in prevention and protection
Pharmacists are well-positioned to integrate RSV (respiratory syncytial virus) vaccination into their practices by identifying at-risk individuals, offering patient education, and proactively recommending RSV vaccines and promoting co-administration with other …
The week in review
Medicines shortages, the rollout of the RSV maternal vaccination program and the implications of the Chemist Warehouse/Sigma merger on franchisees’ bank balances captured the headlines this week Mark Butler the …
RSV vaccine program a global leader
Butler backs NIP-funded RSV vaccine to cut infant hospitalisation numbers Pharmacists are set to help rollout “the most comprehensive protection program for babies in the world”, when the maternal respiratory …
The week in review
Sigma’s proposed merger with Chemist Warehouse continued to dominate the headlines this week, while a nude shopper also attracted the media spotlight Rivals and investment analysts shared their views the …
Guild backs free RSV vaccinations
NIPVIP access to maternal RSV vaccine “truly world-leading”, Guild says Providing pregnant women with free access to the maternal respiratory syncytial virus (RSV) vaccine will help prevent babies from being …
Government seeks deal for RSV vaccine
NIP-funded RSV vaccine for women in late-stage pregnancy on the horizon Talks between the government and Pfizer to deliver a National Immunisation Program (NIP) funded respiratory syncytial virus (RSV) vaccine …